H.R. 2400 · 111th Congress
Strategies to Address Antimicrobial Resistance Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MathesonSponsor4 cosponsors · 4 D
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director).
What it does: CRS summary · Introduced in House · May 13, 2009
Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to establish the Antimicrobial Resistance Office. Requires the Secretary to establish the Public Health Antimicrobial Advisory Board to advise the Director of the Office (Director).
Requires the Director to update the Public Health Action Plan to Combat Antimicrobial Resistance within 18 months.
Requires the Secretary, acting through the Director, the Director of the Centers for Disease Control and Prevention (CDC), and the Director of the National Institutes of Health (NIH), to: (1) develop an antimicrobial resistance strategic research plan; and (2) establish at least ten Antimicrobial Resistance Surveillance and Research Network sites.
Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary to require each sponsor of an approved human antimicrobial drug product sold or distributed in the United States to submit antimicrobial drug sales and distribution data.
Requires that an application for a new animal drug contain information to ensure that reported data is comparable and reliable. Requires (currently, permits) the Secretary to share information reported in a new animal drug application with the Antimicrobial Resistance Task Force.
Sets forth provisions for the Secretary to secure reliable and comparable animal and human antimicrobial drug consumption data.
Requires the Under Secretary for Health of the Department of Veterans Affairs (VA), the Administrator of the Centers for Medicare & Medicaid Services, and the Director to work together to identify and report upon interventions that prevent and control the development of antimicrobial resistance.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Strategies to Address Antimicrobial Resistance Act
Latest action (May 14, 2009): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 13, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.